Patent details

Basic Information

Publication number:

EP3413878

PCT Application Number:

SE2017050128

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177059755

PCT Publication Number:

WO2017138878

First applicant's nationality:

Translation Language:

EPO Publication Language:

English Title of Invention:

ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF

French Title of Invention:

FORMULATION ORALE DE CHOLESTYRAMINE ET UTILISATION ASSOCIÉE

German Title of Invention:

ORALE CHOLESTYRAMINFORMULIERUNGEN UND VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

09/02/2017

Grant date:

14/04/2021

EP Publication Date:

19/12/2018

PCT Publication Date:

17/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/2021

EP B1 Publication Date:

14/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/02/2022

Expiration date:

09/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/04/2021

 

 

Name:

Albireo AB

Address:

Arvid Wallgrens Backe 20, 413 46 Göteborg, Sweden (SE)

Inventor

1

Name:

GILLBERG, Per-Göran

Address:

Sweden (SE)

2

Name:

LINDBERG, Nils-Olof

Address:

Sweden (SE)

3

Name:

GUSTAFSSON, Nils Ove

Address:

Sweden (SE)

4

Name:

ELVERSSON, Jessica

Address:

Sweden (SE)

Priority

Priority Number:

1650157

Priority Date:

09/02/2016

Priority Country:

Sweden (SE)

Classification

IPC classification:

A61K 9/50; A61K 31/554; A61K 31/785; A61K 9/16; A61K 45/06; A61P 1/00; A61P 1/16; A61P 3/00; A61P 43/00; A61P 1/12; A61P 3/06;

Publication

European Patent Bulletin

Issue number:

202115

Publication date:

14/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages